Form 8-K - Current report:
SEC Accession No. 0001144204-18-032151
Filing Date
2018-06-01
Accepted
2018-06-01 06:12:28
Documents
2
Period of Report
2018-05-31
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv495639_8k.htm 8-K 24943
2 EXHIBIT 10.1 tv495639_ex10-1.htm EX-10.1 128777
  Complete submission text file 0001144204-18-032151.txt   154977
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 18873390
SIC: 2834 Pharmaceutical Preparations